Daicel Corp. engages in the manufacture and sale of chemical products. It operates through the following segments: Cellulosic Derivatives, Organic Chemicals, Plastics, Pyrotechnic Devices, and Others. The Cellulosic Derivatives segment engages in the production of various cellulosic derivatives such as cellulose acetate, acetate tow for cigarette filters, and water-soluble polymers. The Organic Chemicals segment offers various solvents and fine chemicals; acetic acid, and chiral columns used for separation of optical isomers. The Plastic segment develops unique products for numerous industrial sectors such as engineering plastics, polymer alloys and cyclic-olefin copolymers; and also develops a variety of plastic processed products such as polystyrene sheets, formed trays, and functional films. The Pyrotechnic Devices segment provides motor vehicle safety devices, airbag inflators, aerospace and defense systems. The Others segment includes membrane and warehousing business. The company was founded on September 8, 1919 and is headquartered in Osaka, Japan.

KH Neochem Co., Ltd. engages in the research, manufacture, and sale of petrochemical products. Its operations are carried out through the following divisions: Basic Chemicals, Performance Materials, and Electronic Materials. The Basic Chemicals division offers solvents and raw materials for plasticizers and resins. The Performance Materials division provides water-based paints, cosmetics, and raw materials for lubricating oils. The Electronic Materials division supplies liquid crystal display panels and semiconductors. The company was founded in November 1966 and is headquartered in Tokyo, Japan.

Del Mar Pharmaceuticals (BC) Ltd., part of Kintara Therapeutics, Inc., is a company headquartered in Vancouver, BC, Canada, that provides drug development services. It was founded by William James Garner, Dennis M. Brown and Jeffrey A. Bacha. Jeffrey A. Bacha is the current CEO, occupying that position since 2010. Kintara Therapeutics, Inc. acquired Del Mar Pharmaceuticals (BC) Ltd. on January 25, 2013 for $0.65 million.

AGC, Inc. engages in the manufacture and sale of glass, electronic materials, and chemicals. It operates through the following segments: Glass, Electronics, Chemicals, Ceramics and Other. The Glass segment provides security glass, fire-resistant glass, heat insulating glass, and automotive glass. The Electronics segment offers glass for display panels, optical thin film products, opto-electronic materials, synthetic quartz products, semiconductor components, and lighting products. The Chemicals segment deals with chlor-alkali and urethane products, water and oil repellents, solvents, gases, and specialty chemicals. The Ceramics and Other segment includes ceramic products, logistics, and financial services. The company was founded by Toshiya Iwasaki on September 8, 1907 and is headquartered in Tokyo, Japan.

Kirin Holdings manufactures and sells alcoholic and non-alcoholic beverages, and pharmaceuticals, and bio-chemicals in Japan and internationally. It operates through four segments: Japan Integrated Beverages Business, Oceania Integrated Beverages Business, Other Overseas Integrated Beverages Business, and Pharmaceuticals and Bio-Chemicals Business. Kirin Holdings' products include beer, happo-shu, wine, whiskey, spirits, soft drinks, dairy products, fruit juices, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products. Moreover, Kirin Holdings engages in the livestock feed and theme park businesses; and management and operation of a chain of Kirin City beer pubs; manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use bulk pharmaceuticals, as well as margarine, jams, and honey. Further, it is involved in the manufacture and sale of Coca-Cola products and other soft drinks, as well as sake; and manufacture and supply of Four Roses bourbon. Kirin Holdings has a strategic collaboration with Mitsui and Onegevity Health for launching a testing system in Japan, as well as to develop nutritional products. Kirin Brewery began operation in 1907 became Kirin Holdings in July 2007, with its headquarters in Tokyo in Japan.

DSM IP Assets BV, a subsidiary of Koninklijke DSM NV, is a company headquartered in Heerlen, the Netherlands, that develops and produces nutrition, pharmacy & material science products.

Develops and supplies in-vivo diagnostic imaging agents and research-based biotechnology supplies

KPC is a pharmaceutical company that engages in the manufacture of pharmaceuticals. Tablets, fluids, ointments, and injectables are among their offerings. Its goal is to improve people's lives by enabling them to achieve more, feel better, and live longer. They have technological machinery, skilled and motivated individuals, and management systems that can handle both quantity and quality of work. They are looking for new ways to improve their performance, raise their integrity to a level of excellence, implement their initiatives, and achieve their goals.

Pola Chemical Industry, Inc. provides cosmetic products, chemicals doranidazole, and pola cosmetics. The company is headquartered in Shinagawa-Ku, Japan.

Shandong Ruian Pharmaceutical Co., Ltd., established on 2007-04-20, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology research and development;Medical Research and Experimental Development;Indoor Sanitation Insecticide Sales;Disinfectant sales(Free of Hazardous Chemicals);Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of packaging materials and products;Specialty Chemicals Sales(Free of Hazardous Chemicals);Synthetic Materials Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug import and export;Technology Import and Export;Import and export;Class III medical device business;Health food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd. is a private company headquartered in Zhongshan, China, focused on pharmaceutical preparations.

Part of Jiangsu Xiansheng Medical Diagnosis Co. Ltd., Jiangsu Simcere Pharmaceutical Co., Ltd. is a Chinese company located in Nanjing that manufactures and sells pharmaceutical products. The firm was founded in 1995.

OncoImmunin Inc. is a private company headquartered in Gaithersburg, MD, that develops therapeutics. The firm was founded in 1994 by Akira Komoriya and Beverly Packard.

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

Koninklijke DSM NV engages in the manufacture and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. It operates through the following segments: Nutrition, Materials, Innovation Center, and Corporate Activities. The Nutrition segment serves the global industries for animal feed, food and beverage, pharmaceuticals, infant nutrition, dietary supplements, and personal care. The Materials segment deals with specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. The Innovation Center segment focuses on innovation and the growth of DSM's existing core business through adjacent technologies. The Corporate Activities segment consists of operating and service activities as well as other several costs. The company was founded in 1902 and is headquartered in Herleen, the Netherlands.

Chemi SpA operates as a chemical pharmaceutical company. It focuses on the development, production and sales of generic active pharmaceutical ingredients, complex to make generics, and peptides. The firm offers pre-filled syringes, vials and oral tablets. The company was founded in 1973 is headquartered in Cinisello Balsamo, Italy.

Guangzhou Qianxiang Biotechnology Co., Ltd., established on 2019-02-27, Business scope includes engineering and technology research and experimental development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Wholesale;Cosmetics Retail;Sales of bio-based materials;Food Additive Sales;Research and development of bio-based material polymerization technology;R&D and application of cell technology;Chemical product sales(No licensed chemical products);Fermentation process optimization technology research and development;Biochemical product technology research and development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Synthetic Materials Sales;R&D of industrial enzyme preparations;internet sales(Except for products that require a license for sale);Sales of packaging materials and products;Personal Hygiene Sales;Information Consulting Service(Not including licensing information consulting services);New material technology promotion service;Daily miscellaneous goods sales;General merchandise sales;Sanitary Ware Sales;Research and development of bio-based materials technology;food sales(Only sell prepackaged food);Import and export;Technology Import and Export

Xiansheng Pharmaceutical Co., Ltd., established on 1998-09-10, The scope of business includes the production of new compound drugs or active ingredient drugs(Including raw materials and preparations);New Anticancer Drugs,Production of new cardiovascular and cerebrovascular drugs;Sell ​​self-produced products(Production and operation according to the licensing items approved by the Provincial Food and Drug Administration);road freight transport.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Taizhou Medical City Guokehua Biomedical Technology Co., Ltd., established on 2016-09-27, Business scope includes technology development of biomedical materials,transfer,consult,Promotion services and related product development;Science and Technology Information Consulting Services;Technology project agency service;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export);food production,Sales,medicine(traditional Chinese medicine,chemical medicine,biological drug),one type,R&D and technical consultation of Class II medical devices,technology transfer,Technical extension services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Inspection and testing service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Biochemical product technology research and development;Chemical product sales(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)